---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-25-034845"
form_type: "8-K"
ticker: "GRCE"
cik: "0001444192"
company_name: "Grace Therapeutics, Inc."
filed_at: "2025-09-12T23:59:59+00:00"
generated_at: "2026-05-17T06:44:07.636430+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Grace Therapeutics shareholders elect 5 directors, approve executive pay and KPMG auditor at annual meeting

## Summary
- Five director nominees elected: Vimal Kavuru, A. Brian Davis, Prashant Kohli, S. George Kottayil, Edward Neugeboren; votes for ranged 6.29M-6.30M.
- Advisory vote on named executive officer compensation passed: 6,178,757 for, 74,002 against, 75,696 abstain, 1,598,490 broker non-votes.
- Ratification of KPMG as independent auditor for FY2026 approved: 7,797,832 for, 127,248 against, 1,865 abstain, no broker non-votes.
- Approximately 57.32% of outstanding shares (7,926,945 of 13,828,562) were represented at the meeting.

## SEC filing metadata
- accession: 0001140361-25-034845
- form_type: 8-K
- ticker: GRCE
- cik: 0001444192
- company_name: Grace Therapeutics, Inc.
- filed_at: 2025-09-12T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1444192/000114036125034845/0001140361-25-034845-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1444192/000114036125034845/ef20055483_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-25-034845
- JSON: https://secwatch.observer/filing/0001140361-25-034845.json
- Plain text: https://secwatch.observer/filing/0001140361-25-034845.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.